Weekly Recap | Caris Life Sciences +4.71%, consensus target above spotWeekly Review·Oct 24, 2026 at 06:00 AMCAI+0.91%
Weekly Recap | Caris Life Sciences +2.9%, most brokers rate it buyWeekly Review·Oct 17, 2026 at 06:42 AMCAI+0.91%
Weekly Recap | Caris Life Sciences +4.95%, most brokers rate it buyWeekly Review·Oct 10, 2026 at 06:15 AMCAI+0.91%
Weekly Recap | Caris Life Sciences -11.51%, consensus target below spotWeekly Review·Oct 3, 2026 at 06:27 AMCAI+0.91%
Weekly Recap | Caris Life Sciences +6.67%, most brokers rate it buyWeekly Review·Sep 26, 2026 at 06:05 AMCAI+0.91%
Weekly Recap | Caris Life Sciences +23.17%, insider sale fails to dent rallyWeekly Review·Sep 19, 2026 at 05:44 AMCAI+0.91%
Weekly Recap | Caris Life Sciences -2.91%, most brokers rate it buyWeekly Review·Sep 12, 2026 at 07:49 AMCAI+0.91%
